Xeris Biopharma Holdings, Inc. (XERS)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.6700 |
| Open | 1.6600 |
| Bid | 1.7900 x 3100 |
| Ask | 1.8700 x 4000 |
| Day's Range | 1.6600 - 1.8700 |
| 52 Week Range | 1.2500 - 3.1700 |
| Volume | |
| Avg. Volume | 1,697,498 |
| Market Cap | 250.732M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for XERS
Related Research
- Xeris Biopharma Holdings, Inc.Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.RatingFair ValueEconomic Moat4 days agoMorningstar
- Simply Wall St.
Bullish Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) insiders filled their treasuries with US$861k worth of stock over last year
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
- Simply Wall St.
Are Institutions Heavily Invested In Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shares?
A look at the shareholders of Xeris Biopharma Holdings, Inc. ( NASDAQ:XERS ) can tell us which group is most powerful...
- TipRanks
Billionaire Israel Englander Pulls the Trigger on These 2 ‘Strong Buy’ Penny Stocks
Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and the reward potentials – than penny stocks. These equities, priced below $5 per share, typically offer high upside potentials. Even a small gain in share price – just a few cents – quickly translates into a high yield return. Of course, the risk is real, too; not every penny stock is going to show th
